Emergent to cut over 130 positions to kick off new year
The Maryland-based manufacturer Emergent BioSolutions is laying off employees and two executives are departing.
In an announcement on Monday, Emergent said that it will lay off 132 employees, as part of its plan to combine its research, product development, and clinical teams into a single “Science & Development” team. The layoffs amount to around 5% of Emergent’s current workforce. According to its annual report to the SEC for Fiscal Year 2021, the manufacturer had 2,416 employees in total. In a statement, Emergent CEO Robert Kramer said that the company will provide resources to help all the employees affected by the layoffs, but no details were provided.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters